PODD Insulet Corporation
Company Analysis
Latest News
🟢 Insulet is trading 4.03% up today as healthcare gains 1.35%
Insulet is trading at $147.62, up 4.03%, with the move appearing most consistent with healthcare-sector strength. - Healthcare is up 1.35%, while the broader...
🟢 Insulet is trading 4% up today as healthcare rises amid defensive rotation
Insulet is trading at $139.32, up 4.02%, as healthcare stocks rise amid a broader defensive rotation; no clear company-specific catalyst was identified. -...
🟢 Insulet is trading 4.5% up in pre-market amid a broader defensive rotation into healthcare
Insulet is trading at $140.00, up +4.53%, in pre-market on October 15, 2026, versus the October 14 close, a move that appears consistent with a broader...
🔴 Insulet is trading 5% down in pre-market with no clear catalyst reported
Insulet is trading 4.88% down at $129.00 in pre-market on October 6, 2026, with no clear company-specific catalyst reported. - Shares closed at $135.62 on...
Insulet Refinances Debt and Unlocks a Bigger Credit Line — But Does a Routine Balance-Sheet Tune-Up Justify a 58% Stock Surge?
Shares of Insulet Corporation rocketed to $219.84 in after-hours trading — up 57.7% from a regular-session close of $139.38 — after the insulin-pump maker...
🟢 Insulet is trading 58% up in after-hours trading after refinancing $475 million in term loans
Insulet is trading at $219.84, up 57.73%, after a September 21, 2026 credit-agreement amendment. - The refinancing replaced approximately $475 million of term...
🟢 Insulet is trading 6% up in pre-market after refinancing $475 million of loans
Insulet is trading 5.91% up at $148.84 after announcing a September 21, 2026 credit-agreement amendment. • Refinanced approximately $475 million of loans •...
🟢 Insulet is trading 4.3% up today amid healthcare-sector strength
Insulet is trading 4.3% up at $137.62 after a sharp multi-session decline, with the move appearing primarily tied to healthcare-sector strength. - XLV is up...
Insulet Announces Departure of Two Board Members, Citing Health and Political Candidacy
Insulet Corporation announced the resignation of two members from its Board of Directors, Timothy J. Scannell and Michael R. Minogue. Mr. Scannell's departure...
Insulet Offered Record $40M State Incentive, Retaining Acton Medical Manufacturing
Massachusetts officials offered Insulet Corp. (PODD) a record $40 million incentive package. The deal aims to keep the Omnipod insulin system manufacturer's...
🔴 Insulet falls 4.0% — Healthcare Stocks Fall as Insurance Crisis Deepens
With Healthcare (XLV) down 2.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector is experiencing a...
🟢 Insulet is trading 6.31% up in after-hours trading with limited support from broader market gains
Insulet is trading 6.31% up at $157.49 after closing at $148.14 on September 2, 2026, with limited support from broader market gains. - No September 2...
Insulet faces class-action deadline, following alleged Omnipod manufacturing defects
Robbins Geller Rudman & Dowd LLP and Faruqi & Faruqi, LLP reminded investors of an August 31, 2026, deadline to seek lead plaintiff status in a class-action...
🟢 Insulet is trading 11.08% up in after-hours trading; immediate trigger remains unclear
Insulet is trading 11.08% up at $164.43 after closing at $148.03 on August 18, 2026; the immediate after-hours trigger remains unclear. - Available August 18...
🟢 Insulet is trading 4.7% up today as healthcare gains 1.59%
Insulet is trading 4.7% up at $146.34, outperforming a broadly weaker market as healthcare gains 1.59% during the regular session. - No new positive...
🟢 Insulet is trading 15.13% up in after-hours trading
Insulet is trading 15.13% up at $167.01 after closing at $145.06 on August 12, 2026; no clear company-specific catalyst explaining the after-hours surge was...
🟢 Insulet is trading 9.51% up in after-hours trading
Insulet is trading 9.51% up at $158.85 in after-hours trading, but the catalyst remains unclear. - Shares closed at $145.06 on August 12, 2026. - No new...
Insulet Corporation faces securities class action lawsuit
Multiple law firms filed a class action lawsuit against Insulet Corporation. The suit alleges violations of federal securities laws. It claims Insulet made...
Insulet Beats on Every Q2 Metric Then Cuts the Outlook — Can the Type 2 Diabetes Bet Still Justify the Stock Price?
Shares of Insulet Corporation cratered 10.1% to $149.98 after the insulin-pump maker delivered a paradox: a strong quarter followed by a weaker road ahead....
🟢 Insulet is trading 4% up today as healthcare stocks gain
Insulet is trading 4% up at $138.59, with healthcare-sector strength providing the immediate backdrop. - It rebounded from the 20.12% decline on August 5. -...